Note: Ingredients listed on restricted chemical lists
EC/CAS
215-647-6/1336-21-6
Name of the chemical
ammonium hydroxide
Concentration
≤0.3
General Information
Version
10.18
Revision date
2026-03-06
Product name
DecaCode Barrier 81 DFC
Emergency telephone
+44 (0) 1978 823456
Icons in SDS
Company Information
company name
Flint Ink (UK) Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
MSDS.UnitedKingdom.Ruabon.PI@flintgrp.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture
Product definition
Mixture Classification according to UK CLP/GHS Eye Irrit. 2, H319
Signal word
Warning
Hazard statements
Causes serious eye irritation.
Prevention
P280 - Wear eye or face protection.
Response
P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 - If eye irritation persists: Get medical advice or attention.
Storage
Not applicable.
Disposal
Not applicable.
Contains
2-methylisothiazol-3(2H)-one. May produce an allergic reaction
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted with child-resistant fastenings : Not applicable.
Tactile warning of danger
Not applicable.
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to UK CLP/GHS Eye Irrit. 2, H319 The product is classified as hazardous according to UK CLP Regulation SI 2019/720 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
